col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

MDPI AG: Pharmaceuticals
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―19 Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection Gwenolé Loas, Pascal Le Corre
2 [GO] 2021―Jul―19 Soluble Angiotensin Converting Enzyme 2 (ACE2) Is Upregulated and Soluble Endothelial Nitric Oxide Synthase (eNOS) Is Downregulated in COVID-19-induced Acute Respiratory Distress Syndrome (ARDS) Alice G. Vassiliou, Alexandros Zacharis, Chrysi Keskinidou, Edison Jahaj, Maria Pratikaki, Parisis Gallos, et al. (+3)
3 [GO] 2021―Jul―16 Current Status of Baricitinib as a Repurposed Therapy for COVID-19 Maha Saber-Ayad, Sarah Hammoudeh, Eman Abu-Gharbieh, Rifat Hamoudi, Hamadeh Tarazi, Taleb H. Al-Tel, Qutayba Hamid
4 [GO] 2021―Jul―15 Use of Monoclonal Antibody to Treat COVID-19 in Children and Adolescents: Risk of Abuse of Prescription and Exacerbation of Health Inequalities Susanna Esposito, Stefano Zona, Andrea Pession, Lorenzo Iughetti, Giovanni Battista Migliori, Nicola Principi
5 [GO] 2021―Jul―12 COVID-19: Failure of the DisCoVeRy Clinical Trial, and Now-New Hopes? Jean Jacques Vanden Eynde
6 [GO] 2021―Jun―23 Identification of SARS-CoV-2 E Channel Blockers from a Repurposed Drug Library Prabhat Pratap Singh Tomar, Miriam Krugliak, Isaiah T. Arkin
7 [GO] 2021―Jun―07 Scaffold Hopping of α-Rubromycin Enables Direct Access to FDA-Approved Cromoglicic Acid as a SARS-CoV-2 MPro Inhibitor Hani A. Alhadrami, Ahmed M. Sayed, Heba Al-Khatabi, Nabil A. Alhakamy, Mostafa E. Rateb
8 [GO] 2021―May―31 Clinical Management of COVID-19: A Review of Pharmacological Treatment Options Ashli M. Heustess, Melissa A. Allard, Dorothea K. Thompson, Pius S. Fasinu
9 [GO] 2021―May―27 Immunotherapeutic Efficacy of IgY Antibodies Targeting the Full-Length Spike Protein in an Animal Model of Middle East Respiratory Syndrome Coronavirus Infection Sherif A. El-Kafrawy, Aymn T. Abbas, Sayed S. Sohrab, Ashraf A. Tabll, Ahmed M. Hassan, Naoko Iwata-Yoshikawa, et al. (+2)
10 [GO] 2021―May―26 New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection Bauso Luana Vittoria, Chiara Imbesi, Gasparo Irene, Gabriella Calì, Alessandra Bitto
11 [GO] 2021―May―20 Hydrotalcite-Niclosamide Nanohybrid as OralFormulation towards SARS-CoV-2 Viral Infections Goeun Choi, Huiyan Piao, N. Sanoj Rejinold, Seungjin Yu, Ki yeok Kim, Geun-woo Jin, Jin-Ho Choy
12 [GO] 2021―May―11 Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection Isabella Zanella, Daniela Zizioli, Francesco Castelli, Eugenia Quiros-Roldan
13 [GO] 2021―Apr―26 COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials Zhi-Peng Yan, Ming Yang, Ching-Lung Lai
14 [GO] 2021―Apr―06 Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients Annalisa Noce, Maria Albanese, Giulia Marrone, Manuela Di Lauro, Anna Pietroboni Zaitseva, Daniela Palazzetti, et al. (+9)
15 [GO] 2021―Apr―06 Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods Tiziana Ginex, Urtzi Garaigorta, David Ramírez, Victoria Castro, Vanesa Nozal, Inés Maestro, et al. (+5)
16 [GO] 2021―Mar―31 Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids Gill Diamond, Natalia Molchanova, Claudine Herlan, John A. Fortkort, Jennifer S. Lin, Erika Figgins, et al. (+6)
17 [GO] 2021―Mar―08 Association between Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) and Reduced Risk of Death in COVID-19 Patients: A Retrospective Cohort Study Gil Darquennes, Pascal Le Corre, Olivier Le Moine, Gwenolé Loas
18 [GO] 2021―Mar―05 Rapamycin: Drug Repurposing in SARS-CoV-2 Infection Jiri Patocka, Kamil Kuca, Patrik Oleksak, Eugenie Nepovimova, Martin Valis, Michal Novotny, Blanka Klimova
19 [GO] 2021―Mar―05 Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches Hossam M. Abdallah, Ali M. El-Halawany, Alaa Sirwi, Amr M. El-Araby, Gamal A. Mohamed, Sabrin R. M. Ibrahim, et al. (+4)
20 [GO] 2021―Feb―25 Evaluation of the Antiviral Activity of Sitagliptin-Glatiramer Acetate Nano-Conjugates against SARS-CoV-2 Virus Nabil A. Alhakamy, Osama A. A. Ahmed, Tarek S. Ibrahim, Hibah M. Aldawsari, Khalid Eljaaly, Usama A. Fahmy, et al. (+3)
21 [GO] 2021―Jan―25 Identification of 37 Heterogeneous Drug Candidates for Treatment of COVID-19 via a Rational Transcriptomics-Based Drug Repurposing Approach Andrea Gelemanović, Tinka Vidović, Višnja Stepanić, Katarina Trajković
22 [GO] 2021―Jan―20 COVID-19-The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection Katarzyna Kotfis, Kacper Lechowicz, Sylwester Drożdżal, Paulina Niedźwiedzka-Rystwej, Tomasz K. Wojdacz, Ewelina Grywalska, et al. (+3)
23 [GO] 2021―Jan―11 Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection Praveen P. N. Rao, Amy Trinh Pham, Arash Shakeri, Amna El Shatshat, Yusheng Zhao, Rahul C. Karuturi, Ahmed A. Hefny
24 [GO] 2021―Jan―07 Immunogenicity of Multiple Doses of pDNA Vaccines against SARS-CoV-2 Iman Almansour, Nabela Calamata Macadato, Thamer Alshammari
25 [GO] 2020―Dec―28 Calming the (Cytokine) Storm: Dimethyl Fumarate as a Therapeutic Candidate for COVID-19 Cara A. Timpani, Emma Rybalka
26 [GO] 2020―Dec―08 Inhibition of SARS-CoV-2 Entry into Host Cells Using Small Molecules Kenana Al Adem, Aya Shanti, Cesare Stefanini, Sungmun Lee
27 [GO] 2020―Dec―04 FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2 Ahmed Mostafa, Ahmed Kandeil, Yaseen A. M. M. Elshaier, Omnia Kutkat, Yassmin Moatasim, Adel A. Rashad, et al. (+14)
28 [GO] 2020―Nov―28 Emetine Is Not Ipecac: Considerations for Its Use as Treatment for SARS-CoV2 Martin D. Bleasel, Gregory M. Peterson
29 [GO] 2020―Nov―27 Repurposing of Plasminogen: An Orphan Medicinal Product Suitable for SARS-CoV-2 Inhalable Therapeutics Anna Maria Piras, Ylenia Zambito, Maurizio Lugli, Baldassare Ferro, Paolo Roncucci, Filippo Mori, et al. (+4)
30 [GO] 2020―Nov―10 Role of 2-[18F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review Salvatore Annunziata, Roberto C. Delgado Bolton, Christel-Hermann Kamani, John O. Prior, Domenico Albano, Francesco Bertagna, Giorgio Treglia
31 [GO] 2020―Oct―17 Effect of Tocilizumab in Hospitalized Patients with Severe COVID-19 Pneumonia: A Case-Control Cohort Study Benjamin Rossi, Lee S. Nguyen, Philippe Zimmermann, Faiza Boucenna, Louis Dubret, Louise Baucher, et al. (+7)
32 [GO] 2020―Oct―16 Medicinal Plants to Strengthen Immunity during a Pandemic Olga Babich, Stanislav Sukhikh, Alexander Prosekov, Lyudmila Asyakina, Svetlana Ivanova
33 [GO] 2020―Sep―09 Can Nuclear Imaging of Activated Macrophages with Folic Acid-Based Radiotracers Serve as a Prognostic Means to Identify COVID-19 Patients at Risk? Cristina Müller, Roger Schibli, Britta Maurer
34 [GO] 2020―Sep―01 Zinc(II)-The Overlooked Éminence Grise of Chloroquine’s Fight against COVID-19? Aleksandra Hecel, Małgorzata Ostrowska, Kamila Stokowa-Sołtys, Joanna Wątły, Dorota Dudek, Adriana Miller, et al. (+5)
35 [GO] 2020―Aug―10 Emerging Therapeutic Modalities against COVID-19 Shipra Malik, Anisha Gupta, Xiaobo Zhong, Theodore P. Rasmussen, Jose E. Manautou, Raman Bahal
36 [GO] 2020―Jul―28 Squalene Emulsion Manufacturing Process Scale-Up for Enhanced Global Pandemic Response Tony Phan, Christian Devine, Erik D. Laursen, Adrian Simpson, Aaron Kahn, Amit P. Khandhar, et al. (+5)
37 [GO] 2020―Jul―27 Immune Pathogenesis of COVID-19 Intoxication: Storm or Silence? Mikhail Kiselevskiy, Irina Shubina, Irina Chikileva, Suria Sitdikova, Igor Samoylenko, Natalia Anisimova, et al. (+4)
38 [GO] 2020―Jul―20 Substance Use Disorder in the COVID-19 Pandemic: A Systematic Review of Vulnerabilities and Complications Yufeng Wei, Rameen Shah
39 [GO] 2020―Jul―06 Cancer Patients Have a Higher Risk Regarding COVID-19 - and Vice Versa? Franz Geisslinger, Angelika M. Vollmar, Karin Bartel
40 [GO] 2020―Jun―25 Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection Andreia Palmeira, Emília Sousa, Aylin Köseler, Ramazan Sabirli, Tarık Gören, İbrahim Türkçüer, et al. (+3)
41 [GO] 2020―May―14 The Rationale for Potential Pharmacotherapy of COVID-19 Maha Saber-Ayad, Mohamed A. Saleh, Eman Abu-Gharbieh
42 [GO] 2020―May―14 COVID-19: An Update About the Discovery Clinical Trial Jean Jacques Vanden Eynde
43 [GO] 2020―Apr―13 COVID-19: A Brief Overview of the Discovery Clinical Trial Jean Jacques Vanden Eynde
44 [GO] 2020―Mar―23 Emetine, Ipecac, Ipecac Alkaloids and Analogues as Potential Antiviral Agents for Coronaviruses Martin D Bleasel, Gregory M Peterson


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.005 sec